Indeed, CAR T-cells engineered to express an anti-CD105 nanobody from the AAVS1 site displayed hallmark features of activated cytotoxic T-cells when co-cultured in vitro with CD105-positive cancer cells: they proliferated, secreted pro-inflammatory cytokines, and efficiently eliminated target cells in vitro. Here, ENG is linked to cancer.